We are excited to share the highly anticipated second part of our riveting technology highlights podcast series, broadcasting straight from the heart of the annual American Urologic Association meeting in Chicago, Illinois! The world of BPH treatment options is booming with innovation! Get ready for an exclusive sneak peek into several upcoming technologies Dr. Pohlman discovered while scouring the exhibition hall at the American Urologic Association annual meeting. This week, we focus on the incredible advancements in BPH technology and share insightful interviews with representatives from pioneering companies and urologists utilizing these cutting-edge tools. While we will only scratch the surface of the fan favorites at this year's conference, you can rest assured we will keep you up to speed on other ground-breaking technologies throughout the year! Get ready to stay ahead of the curve on our podcast journey! In this episode, we dive into the intriguing world of cutting-edge solutions for an enlarged prostate, known as benign prostatic hyperplasia or BPH. Prepare yourself for an exclusive glimpse behind the scenes as we uncover the latest advancements that will revolutionize prostate management. Whether you are concerned about your own health or that of a loved one, this is an episode you cannot afford to miss! Join us as we unlock the mysteries of prostate health and equip you with the knowledge to navigate this crucial aspect of well-being! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: Dr. Pohlman is already utilizing Optilume BPH for managing urethral strictures in his practice. He explains how it works. Dr. Pohlman talks with Ian Schorn, Vice President of Clinical Affairs at Urotronic, about using Optilume for managing BPH. Ian Schorn explains something unique about Optilume BPH. The clinical data on the Optilume device has shown very good outcomes in terms of flow rate improvement after treatment. Urotronic hopes to get official FDA approval within the next few months for its Optilume technology. Dr. Pohlman shares the secret to the successful results of Optilume. Dr. Pohlman describes the new stent devices now emerging for BPH and explains which ones will most likely rise to the top, in terms of outcomes and urologist preference. Dr. Pohlman talks to the CEO of Butterfly Medical, Idan Geva, about their new technology for BPH. How does Butterfly Medical's new nitinol implant compare with other available technologies? What is Aquablation therapy? Dr. Lewis Kriteman, from Georgia Urology, discusses the benefits of Aquablation therapy and explains how it compares with the procedures he used before. Dr. Pohlman was the first urologist in the Seven State Region, including Nebraska, Kansas, Iowa, Missouri, Montana, Wyoming, and Colorado, to offer Aquablation. It is encouraging and exciting to see the continuous advancements in technology and techniques for managing BPH! Today's tantalizing glimpse into emerging technologies at the AUA annual meeting is just the beginning. We will delve even deeper into these breakthroughs in future episodes. Stay connected by subscribing to our podcast to ensure you are always in the loop, and get ready for a journey of knowledge and discovery as we explore the forefront of BPH management! Links: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd Get your free What To Expect Guide (or find the link on our podcast website) Join our Facebook group Follow Dr. Pohlman on Twitter and Instagram Go to the Prostate Health Academy to sign up. You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Urotronic Butterfly Medical Georgia Urology

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related